Drug Type Biological products |
Synonyms |
Target- |
Action modulators |
Mechanism Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 2 | United States | 10 Aug 2021 | |
COVID-19 | Phase 2 | United States | 14 May 2020 | |
Bacterial Infections | Phase 2 | United States | 20 Jul 2019 |